Quick Answer
Traws Pharma, Inc. reported Net Income of -$166.52 million for fiscal year 2024.
Traws Pharma, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2024 | -$166.52M | -778.8% |
| 2023 | -$18.95M | +11.9% |
| 2019 | -$21.50M | -4.5% |
| 2018 | -$20.57M | +14.6% |
| 2017 | -$24.09M | -22.5% |
| 2016 | -$19.67M | +18.0% |
| 2015 | -$23.98M | +62.3% |
| 2014 | -$63.68M | -1.8% |
| 2013 | -$62.54M | -109.1% |
| 2012 | -$29.91M | -13.8% |
| 2011 | -$26.29M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$3.96M | +53.3% | -333.0% |
| June 30, 2025 | -$915.0K | +99.3% | -104.3% |
| March 31, 2025 | $21.49M | +531.3% | +353.6% |
| September 30, 2024 | -$8.47M | -78.8% | +93.1% |
| June 30, 2024 | -$123.14M | -2797.5% | -2371.3% |
| March 31, 2024 | -$4.98M | — | -5.1% |
| September 30, 2023 | -$4.74M | — | -11.5% |
| June 30, 2023 | -$4.25M | — | +7.5% |
- Traws Pharma, Inc. showed a decrease of -778.8% in Net Income compared to the prior fiscal year.
- Over the 2011–2024 period, Traws Pharma, Inc.’s net income has declined by 533.3% (from -$26.29 million to -$166.52 million).
- The most recent figure is from Traws Pharma, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: